PubRank

Kuo-Wei Chang

Author PubWeight™ 65.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010 2.18
2 miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010 1.36
3 Genome-wide profiling of oral squamous cell carcinoma. J Pathol 2004 1.33
4 The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS One 2008 1.18
5 Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Mol Cancer Ther 2010 1.11
6 MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 2011 1.08
7 Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer 2004 1.07
8 miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer 2013 1.06
9 The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol 2010 1.05
10 Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 2006 1.05
11 Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2011 1.05
12 Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med 2004 1.02
13 The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One 2012 1.01
14 Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 2006 1.01
15 Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res 2007 1.00
16 Detection and screening of oral cancer and pre-cancerous lesions. J Chin Med Assoc 2009 1.00
17 IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma. Mol Cancer Res 2008 0.99
18 The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 2003 0.98
19 Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells. Cancer Lett 2004 0.98
20 Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas. Oral Oncol 2007 0.97
21 MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol 2008 0.97
22 Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 2005 0.97
23 Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006 0.96
24 MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr Opin Otolaryngol Head Neck Surg 2013 0.96
25 Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 2005 0.94
26 Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 2004 0.93
27 Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med 2008 0.93
28 Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 2005 0.92
29 miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One 2013 0.91
30 Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol 2011 0.91
31 miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett 2013 0.91
32 Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol 2010 0.90
33 Rapidly growing mass in mandibular gingiva. J Oral Maxillofac Surg 2004 0.89
34 Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase. Toxicol Lett 2004 0.89
35 Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol 2010 0.89
36 Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy 2010 0.88
37 miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis 2014 0.88
38 Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol 2009 0.88
39 Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers. J Pathol 2005 0.87
40 Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients. Head Neck 2011 0.86
41 Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 2009 0.86
42 Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. J Oral Pathol Med 2008 0.85
43 Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling. Dev Biol 2010 0.85
44 MICA and MICB overexpression in oral squamous cell carcinoma. J Oral Pathol Med 2007 0.85
45 In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines. Microbiol Res 2013 0.85
46 Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma. J Oral Maxillofac Surg 2004 0.85
47 Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma. Head Neck 2012 0.84
48 Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med 2003 0.84
49 K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression. Int J Cancer 2014 0.83
50 Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro. J Pathol 2010 0.82
51 Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med 2004 0.82
52 Areca nut extract upregulates vimentin by activating PI3K/AKT signaling in oral carcinoma. J Oral Pathol Med 2010 0.82
53 The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use. J Oral Pathol Med 2002 0.82
54 Effect of nitride film coatings on cell compatibility. Dent Mater 2008 0.81
55 Regulation of IGFBP-5 expression during tumourigenesis and differentiation of oral keratinocytes. J Pathol 2002 0.81
56 MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol 2011 0.80
57 Enhanced filopodium formation and stem-like phenotypes in a novel metastatic head and neck cancer cell model. Oncol Rep 2013 0.80
58 The molecular markers for prognostic evaluation of areca-associated buccal squamous cell carcinoma. J Oral Pathol Med 2004 0.80
59 The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo. Cancer Lett 2006 0.79
60 Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J Oral Pathol Med 2003 0.79
61 Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma--evidence for COX-2 induction by areca quid ingredients in oral keratinocytes. J Oral Pathol Med 2003 0.79
62 Ultrafast characterization of phase-change material crystallization properties in the melt-quenched amorphous phase. Nano Lett 2014 0.78
63 Molecular and cellular cues of diet-associated oral carcinogenesis--with an emphasis on areca-nut-induced oral cancer development. J Oral Pathol Med 2014 0.78
64 The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas. Oral Oncol 2011 0.78
65 Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med 2004 0.78
66 Association between areca-stimulated vimentin expression and the progression of head and neck cancers. Head Neck 2011 0.78
67 Areca nut extract treatment down-regulates involucrin in normal human oral keratinocyte through P13K/AKT activation. Oral Oncol 2006 0.78
68 Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas. J Oral Pathol Med 2005 0.78
69 Sarcomas and sarcomatoid tumor after radiotherapy of oral squamous cell carcinoma: analysis of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 0.78
70 Areca nut extract-treated gingival fibroblasts modulate the invasiveness of polymorphonuclear leukocytes via the production of MMP-2. J Oral Pathol Med 2009 0.77
71 Lipopolysaccharide induces the migration of human dental pulp cells by up-regulating miR-146a. J Endod 2012 0.77
72 Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med 2005 0.75
73 Rapid in vivo assay for topical oral cancer chemopreventive agents. Int J Oncol 2002 0.75